Prognostic Significance of the Mitotic Index Using the Mitosis Marker Anti–Phosphohistone H3 in Meningiomas
Authors:
Open Access
- 1 July 2007
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 128 (1) , 118-125
Abstract
Mitotic activity is one of the most reliable prognostic factors in meningiomas. The identification of mitotic figures (MFs) and the areas of highestKeywords
This publication has 13 references indexed in Scilit:
- Assessment and Prognostic Significance of Mitotic Index Using the Mitosis Marker Phospho-histone H3 in Low and Intermediate-grade Infiltrating AstrocytomasAmerican Journal of Surgical Pathology, 2006
- Two Mitosis-Specific Antibodies, MPM-2 and Phospho-Histone H3 (Ser28), Allow Rapid and Precise Determination of Mitotic ActivityAmerican Journal of Surgical Pathology, 2006
- The Mitosis-Specific Antibody Anti-Phosphohistone-H3 (PHH3) Facilitates Rapid Reliable Grading of Meningiomas According to WHO 2000 CriteriaAmerican Journal of Surgical Pathology, 2004
- Chromatin Condensation Is Not Associated with ApoptosisJournal of Biological Chemistry, 1998
- The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomasCancer, 1998
- Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensationChromosoma, 1997
- Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/feulgen stainings, and cytogeneticsActa Neurochirurgica, 1995
- Cell cycle-dependent suppressive effect of histone H1 on mitosis-specific H3 phosphorylation.Journal of Biological Chemistry, 1993
- Surgical Pathology of the Nervous System and Its CoveringsJournal of Neuropathology & Experimental Neurology, 1983
- THE RECURRENCE OF INTRACRANIAL MENINGIOMAS AFTER SURGICAL TREATMENTJournal of Neurology, Neurosurgery & Psychiatry, 1957